Liposomal mitomycin C prodrug (Promitil) compared to mitomycin C in chemoradiotherapy in preclinical models of colorectal cancer

被引：0
|
作者：
Tian, Xi
Minh Nguyen
Ohana, Patricia
Gabizon, Alberto A.
Wang, Andrew
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Lipomedix Pharmaceut Ltd, Jerusalem, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e13525
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13525
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Salvage chemotherapy in metastatic colorectal cancer with the combination of capecitabine and mitomycin C
    Zygulska, A. L.
    Krzemieniecki, K.
    NEOPLASMA, 2015, 62 (05) : 793 - 797
  • [32] Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: Insights of the mechanism of action
    Zalipsky, Samuel
    Saad, Maha
    Kiwan, Radwan
    Ber, Elizabeth
    Yu, Ning
    Minko, Tamara
    JOURNAL OF DRUG TARGETING, 2007, 15 (7-8) : 518 - 530
  • [33] A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer
    Ferrarotto, Renata
    Machado, Karime
    Mak, Milena P.
    Shah, Neeraj
    Takahashi, Tiago K.
    Costa, Frederico P.
    Overman, Michael J.
    Kopetz, Scott
    Hoff, Paulo M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (06) : 820 - 826
  • [34] Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis
    Leung, V.
    Huo, Y. R.
    Liauw, W.
    Morris, D. L.
    EJSO, 2017, 43 (01): : 144 - 149
  • [35] Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases
    Schneebaum, S
    Arnold, MW
    Staubus, A
    Young, DC
    Dumond, D
    Martin, EW
    ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (01) : 44 - 50
  • [36] SALVAGE CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER WITH COMBINATION OF CAPECITABINE AND MITOMYCIN C
    Aneta, Zygulska
    Krzysztof, Krzemieniecki
    ANNALS OF ONCOLOGY, 2014, 25
  • [37] Pegylated Liposomal Mitomycin C Lipidic Prodrug and Palliative Radiotherapy- a Phase 1B Study
    Sapir, E.
    Pfeffer, R.
    Wygoda, M.
    Levy, A.
    Corn, B.
    Ohana, P.
    Gabizon, A.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1246 - S1246
  • [38] Mitomycin C for the treatment of bladder cancer
    Volpe, A.
    Racioppi, M.
    D'Agostino, D.
    Cappa, E.
    Filianoti, A.
    Bassi, P. F.
    MINERVA UROLOGICA E NEFROLOGICA, 2010, 62 (02) : 133 - 144
  • [39] Enhancement of photodynamic therapy by mitomycin C: A preclinical and clinical study
    Baas, P
    vanGeel, IPJ
    Oppelaar, H
    Meyer, M
    Beynen, JH
    vanZandwijk, N
    Stewart, FA
    BRITISH JOURNAL OF CANCER, 1996, 73 (08) : 945 - 951
  • [40] Microsphere-delivered mitomycin C (MMC) and the effects on cancer cells of combining mitomycin C and doxorubicin
    Cheung, R
    Ying, Y
    Wu, XY
    Rauth, A
    Marcon, N
    JOURNAL OF CONTROLLED RELEASE, 2003, 91 (1-2) : 240 - 242
12345